Ontrak (OTRK) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Nov, 2025Executive summary
Q4 2024 revenue was $3.1 million, down 11% year-over-year; full year revenue was $10.8 million, down 15% year-over-year.
Secured three new regional health plan customers and four health plan expansions in the past 14 months, including Medicaid, HARP, commercial, and Medicare Advantage plans.
Launched WholeHealth Plus with Intermountain Health, enrolling over 325 members in the first month, and over 450 members with the Northeast Regional Plan.
Q4 operating loss was $(4.4) million, a 16% improvement year-over-year; full year operating loss was $(17.8) million, a 16% improvement year-over-year.
Active sales pipeline with six late-stage health plan prospects and 20 additional prospects, representing over 15 million lives.
Financial highlights
Q4 2024 revenue was $3.1 million, down 11% year-over-year due to a lost customer, partially offset by a new customer.
Q4 net loss was $(5.2) million, or $(9.54) diluted net loss per share; full year net loss was $(25.5) million, or $(17.02) diluted net loss per share.
Gross margin for Q4 was 61%, slightly down from 62% in Q3 and 64.6% in Q4 2023.
Operating cash flow for Q4 was -$4.3 million; net cash used in operating activities was $(13.4) million for 2024.
Year-end cash reserves were $5.7 million, down from $9.7 million last year.
Outlook and guidance
Q1 2025 revenue expected between $2 million and $2.3 million, a 27%-36% sequential decrease due to customer loss and ramp-up of new contracts.
Revenue run rate expected to recover by Q2 2025 as new customer implementations stabilize.
Management expects pipeline prospects, including a large Midwest plan, could more than double run-rate revenue.
Latest events from Ontrak
- Q2 revenue fell 17% to $2.5M; a major new contract is set to double the outreach pool.OTRK
Q2 20242 Feb 2026 - Q3 revenue fell 31% as liquidity and customer risks persist despite new contracts and launches.OTRK
Q3 202414 Jan 2026 - Stockholders will vote on director elections, equity plans, a reverse split, and key governance items.OTRK
Proxy Filing2 Dec 2025 - Key votes include director elections, a new equity plan, and a reverse stock split to retain Nasdaq listing.OTRK
Proxy Filing2 Dec 2025 - Virtual meeting to vote on directors, compensation, and a reverse stock split proposal.OTRK
Proxy Filing2 Dec 2025 - Urgent capital raise with high dilution risk, customer loss, and Nasdaq delisting threat.OTRK
Registration Filing29 Nov 2025 - Warrant-driven offering aims to raise $13.7M amid customer, debt, and dilution risks.OTRK
Registration Filing29 Nov 2025 - Raising up to $6M via stock and warrants amid severe financial, customer, and dilution risks.OTRK
Registration Filing29 Nov 2025 - Q1 revenue fell 25% as losses widened, but member growth and new financing offer hope.OTRK
Q1 202514 Nov 2025